FDA.reportPublic FDA data

CVS Motion Sickness Fast Melting

Manufacturer
CVS Pharmacy, Inc.
Effective date
2025-12-30
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 01:29:37

Label at a glance#

ProductCVS Motion Sickness Fast Melting
Active ingredientMECLIZINE HYDROCHLORIDE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet) 
Meclizine hydrochloride 25mg

OTC - PURPOSE SECTION

Purpose
Meclizine hydrochloride    Antiemetic

INDICATIONS & USAGE SECTION

Uses
■ For the prevention and treatment of the nausea, vomiting, or dizziness associated with motion sickness.

WARNINGS SECTION

​Warnings

OTC - DO NOT USE SECTION

Do not use in children under 12 years of age unless directed by a physician

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have
■ glaucoma   ■ a breathing problem such as emphysema or chronic bronchitis
■ difficulty in urination due to enlargement of the prostate gland

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a physician or pharmacist before use if you are
■ taking sedatives or tranquilizers

OTC - WHEN USING SECTION

When using this product
■ you may get drowsy   ■ avoid alcoholic beverages
■ be careful when driving a motor vehicle or operating machinery
■ alcohol, sedatives, and tranquilizers may increase the drowsiness effect

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions
To prevent motion sickness take it at least one hour before traveling    
Adults and children 12 years of age and over:  take 1 to 2 (25 to 50 mg) tablets once daily, or as directed by a physician.

OTHER SAFETY INFORMATION

Other information
■ Store at 20-30°C (68-86°F)

INACTIVE INGREDIENT SECTION

Inactive ingredients
acesulfame potassium, erythritol, hydroxypropyl cellulose, colloidal silicon dioxide, mannitol, menthol, sodium stearyl fumarate, yellow ferric oxide.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CartonCarton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1663815meclizine HCl 25 MG Disintegrating Oral TabletPSN6
1663815meclizine hydrochloride 25 MG Disintegrating Oral TabletSCD6
1663815meclizine HCl 25 MG Disintegrating Oral TabletSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MECLIZINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130050428473290GTIN-13: 0050428473290
EAN-13: 0050428473290
GTIN-12: 050428473290
UPC-A: 050428473290
GTIN storage (14 digits): 00050428473290		CVSMotCart.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ac6963c4-31c6-325f-ee58-83a0a06597adProduct name520221206
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59779-534-01CVS Motion Sickness Fast Melting2 in 1 CARTONTABLET, ORALLY DISINTEGRATING26
59779-534-01CVS Motion Sickness Fast Melting6 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING66

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
MECLIZINE HYDROCHLORIDEACTIVE INGREDIENTHDP7W44CIO1
MECLIZINEACTIVE MOIETY3L5TQ845701
ACESULFAME POTASSIUMINACTIVE INGREDIENT23OV73Q5G91
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU41
ERYTHRITOLINACTIVE INGREDIENTRA96B954X61
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRT1
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671P1
LEVOMENTHOLINACTIVE INGREDIENTBZ1R15MTK71
MANNITOLINACTIVE INGREDIENT3OWL53L36A1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59779-53459779-534-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
NameUNIIKind
HYDROXYPROPYL CELLULOSE, UNSPECIFIED9XZ8H6N6OHIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
ERYTHRITOLRA96B954X6IACT
MANNITOL3OWL53L36AIACT
ACESULFAME POTASSIUM23OV73Q5G9IACT
FERRIC OXIDE YELLOWEX438O2MRTIACT
SODIUM STEARYL FUMARATE7CV7WJK4UIIACT
LEVOMENTHOLBZ1R15MTK7IACT
MECLIZINE HYDROCHLORIDEHDP7W44CIOACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 14 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MANNITOLMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, ORALLY DISINTEGRATING / ORAL68 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
HYDROXYPROPYL CELLULOSE (TYPE H)HYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PTABLET, ORALLY DISINTEGRATING / ORAL4 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
COLLOIDAL SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, ORALLY DISINTEGRATING / ORAL68 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
HYDROXYPROPYL CELLULOSE (TYPE H)HYDROXYPROPYL CELLULOSE (1600000 WAMW)RFW2ET671PTABLET, ORALLY DISINTEGRATING / ORAL4 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, ORALLY DISINTEGRATING / ORAL2 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LEVOMENTHOLLEVOMENTHOLBZ1R15MTK7TABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTTABLET, ORALLY DISINTEGRATING / ORAL2 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
ACESULFAME POTASSIUMACESULFAME POTASSIUM23OV73Q5G9TABLET, ORALLY DISINTEGRATING / ORAL24 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
LEVOMENTHOLLEVOMENTHOLBZ1R15MTK7TABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
ACESULFAME POTASSIUMACESULFAME POTASSIUM23OV73Q5G9TABLET, ORALLY DISINTEGRATING / ORAL24 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING / ORAL4364 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UITABLET, ORALLY DISINTEGRATING / ORAL153 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UITABLET, ORALLY DISINTEGRATING / ORAL153 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CVS Motion Sickness Fast MeltingMECLIZINE HYDROCHLORIDECVS Pharmacy, Inc.2a723bce-a581-4558-b028-22f1f9125dd52025-12-30WarningsExact identifier
ndc (package): 59779-534-01
ndc (product): 59779-534
ndc11 (package): 59779053401
spl id: 4739009f-12dd-76f8-e063-6394a90af3f5
spl set id: 2a723bce-a581-4558-b028-22f1f9125dd5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.